LYMPHOID TISSUE HYPERPLASIA

This adverse event was reported 354 times

These drugs are most commonly taken by patients reporting LYMPHOID TISSUE HYPERPLASIA:

# Drug Count
0 DASATINIB 31
1 ADALIMUMAB 26
2 INFLIXIMAB 19
3 METHOTREXATE 19
4 METHOTREXATE SODIUM 19
5 LAMOTRIGINE 14
6 ETANERCEPT 13
7 RITUXIMAB 13
8 TACROLIMUS 13
9 TACROLIMUS EXTENDED-RELEASE CAPSULES 12
See all common drugs associated with LYMPHOID TISSUE HYPERPLASIA

LYMPHOID TISSUE HYPERPLASIA is most prevalent among patients taking these drugs:

# Drug Count Frequency
0 BENZOCAINE AND CHLOROXYLENOL 1 0.0222
1 HOMOSALATE, OCTISALATE, AVOBENZONE, AND DIMETHICONE 1 0.0217
2 AURANOFIN 2 0.0098
3 DASATINIB 31 0.0033
4 PENICILLAMINE 2 0.0022
5 BROMOCRIPTINE MESYLATE 1 0.0015
6 MECASERMIN 1 0.0012
7 ALOSETRON HYDROCHLORIDE 1 0.0012
8 CHLORPROMAZINE HYDROCHLORIDE 1 0.0010
9 HUMAN RHO(D) IMMUNE GLOBULIN 1 0.0010
See all drugs enriched for association with LYMPHOID TISSUE HYPERPLASIA